Kardio Brynow Sp. z o.o.

At Kardio Brynow Sp. z o.o. in Katowice, most trials focus on cardiovascular diseases, especially hypertrophic cardiomyopathy, heart failure, hypertension, and atherosclerotic cardiovascular disease. The studies are designed to evaluate new treatments, improve symptom control, and better understand how therapies affect heart structure and function.

• Testing new therapies for symptomatic hypertrophic cardiomyopathy, including obstructive and non-obstructive forms
• Assessing treatment options for heart failure across reduced, mildly reduced, and preserved ejection fraction
• Studying approaches to lower cardiovascular risk in people with hypertension or established disease

These trials aim to improve daily functioning, reduce symptoms, and support better long-term outcomes for patients with complex heart conditions.

The site also participates in research within congenital and hereditary diseases, with a strong emphasis on inherited heart disorders such as hypertrophic cardiomyopathy. These studies help clarify how genetic heart conditions affect patients and whether emerging therapies can ease obstruction, improve exercise ability, and reduce disease burden.

• Investigating treatments for symptomatic obstructive hypertrophic cardiomyopathy
• Evaluating care options for non-obstructive hypertrophic cardiomyopathy
• Exploring ways to improve heart muscle structure and patient-reported health status

This research supports a deeper understanding of inherited cardiac disorders and their impact on quality of life.

Clinical trials in nutritional and metabolic diseases at Kardio Brynow Sp. z o.o. include studies linked to cardiometabolic risk and inflammation-related heart disease. The research is aimed at testing whether newer therapies can reduce cardiovascular events, improve plaque characteristics, and better control risk factors that contribute to heart disease.

• Evaluating treatments for people with high cardiovascular risk and established disease
• Studying therapies for atherosclerotic cardiovascular disease and coronary plaque burden
• Assessing whether inflammation-targeted approaches can improve outcomes in heart failure

Together, these studies reflect a broader effort to address the metabolic drivers of cardiovascular illness and prevent serious complications.